A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.

Source:http://linkedlifedata.com/resource/pubmed/id/18188764

Download in:

View as

General Info

PMID
18188764